Myocardial stress and autophagy: Mechanisms and potential therapies

Nature Reviews Cardiology

Volumn 14, Issue 7, 2017, Pages 412-425

  Delbridge, Lea M D ^a   Mellor, Kimberley M ^b   Taylor, David J ^c   Gottlieb, Roberta A ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLADENINE; ATORVASTATIN; DIAZOXIDE; DORSOMORPHIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; MICRORNA; RANOLAZINE; RAPAMYCIN; URIDINE TRIPHOSPHATE; VERAPAMIL; WORTMANNIN;

AUTOPHAGY; CLINICAL TRIAL (TOPIC); DIABETIC CARDIOMYOPATHY; DRUG EFFICACY; GLYCOPHAGY; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART STRESS; HUMAN; MACROAUTOPHAGY; MICROAUTOPHAGY; NONHUMAN; PATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; CARDIAC MUSCLE; DRUG DEVELOPMENT; DRUG EFFECT; ENERGY METABOLISM; HOMEOSTASIS; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

AUTOPHAGY; DRUG DISCOVERY; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; MYOCARDIUM; STRESS, PHYSIOLOGICAL;

EID: 85016553192     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2017.35     Document Type: Review

References (177)

1. Senyo, S. E., Lee, R. T. & Kühn, B. Cardiac regeneration based on mechanisms of cardiomyocyte proliferation and differentiation. Stem Cell Res. 13, 532-541 (2014).
2. Nakai, A. et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat. Med. 13, 619-624 (2007).
3. Kuma, A. et al. The role of autophagy during the early neonatal starvation period. Nature 432, 1032-1036 (2004).
4. Reichelt, M. E., Mellor, K. M., Curl, C. L., Stapleton, D. & Delbridge, L. M. Myocardial glycophagy - a specific glycogen handling response to metabolic stress is accentuated in the female heart. J. Mol. Cell. Cardiol. 65, 67-75 (2013).
5. Li, W. W., Li, J. & Bao, J. K. Microautophagy: lesser-known self-eating. Cell. Mol. Life Sci. 69, 1125-1136 (2012).
6. Jackson, M. P. & Hewitt, E. W. Cellular proteostasis: degradation of misfolded proteins by lysosomes. Essays Biochem. 60, 173-180 (2016).
7. Sahu, R. et al. Microautophagy of cytosolic proteins by late endosomes. Dev. Cell 20, 131-139 (2011).
8. Cadete, V. J. et al. Formation of mitochondrial-derived vesicles is an active and physiologically relevant mitochondrial quality control process in the cardiac system. J. Physiol. 594, 5343-5362 (2016).
9. Tanida, I. Autophagy basics. Microbiol. Immunol. 55, 1-11 (2011).
10. Tooze, S. A. & Yoshimori, T. The origin of the autophagosomal membrane. Nat. Cell Biol. 12, 831-835 (2010).
11. Maejima, Y., Isobe, M. & Sadoshima, J. Regulation of autophagy by Beclin 1 in the heart. J. Mol. Cell. Cardiol. 95, 19-25 (2016).
12. Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12, 1-222 (2016).
13. Nishida, Y. et al. Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature 461, 654-658 (2009).
14. Behrends, C., Sowa, M. E., Gygi, S. P. & Harper, J. W. Network organization of the human autophagy system. Nature 466, 68-76 (2010).
15. Huber, L. A. & Teis, D. Lysosomal signaling in control of degradation pathways. Curr. Opin. Cell Biol. 39, 8-14 (2016).
16. Itakura, E., Kishi-Itakura, C. & Mizushima, N. The hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes. Cell 151, 1256-1269 (2012).
17. Yang, Z., Huang, J., Geng, J., Nair, U. & Klionsky, D. J. Atg22 recycles amino acids to link the degradative and recycling functions of autophagy. Mol. Biol. Cell 17, 5094-5104 (2006).
18. Gottlieb, R. A., Andres, A. M., Sin, J. & Taylor, D. P. Untangling autophagy measurements: all fluxed up. Circ. Res. 116, 504-514 (2015).
19. Gurney, M. A. et al. Measuring cardiac autophagic flux in vitro and in vivo. Methods Mol. Biol. 1219, 187-197 (2015).
20. Martins-Marques, T., Ribeiro-Rodrigues, T., Pereira, P., Codogno, P. & Girao, H. Autophagy and ubiquitination in cardiovascular diseases. DNA Cell Biol. 34, 243-251 (2015).
21. Korac, J. et al. Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates. J. Cell Sci. 126, 580-592 (2013).
22. Tan, V. P. & Miyamoto, S. Nutrient-sensing mTORC1: integration of metabolic and autophagic signals. J. Mol. Cell. Cardiol. 95, 31-41 (2016).
23. Egan, D., Kim, J., Shaw, R. J. & Guan, K. L. The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR. Autophagy 7, 643-644 (2011).
24. Martina, J. A., Chen, Y., Gucek, M. & Puertollano, R. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy 8, 903-914 (2012).
25. Oyabu, J. et al. Autophagy-mediated degradation is necessary for regression of cardiac hypertrophy during ventricular unloading. Biochem. Biophys. Res. Commun. 441, 787-792 (2013).
26. Rifki, O. F., Bodemann, B. O., Battiprolu, P. K., White, M. A. & Hill, J. A. RalGDS-dependent cardiomyocyte autophagy is required for load-induced ventricular hypertrophy. J. Mol. Cell. Cardiol. 59, 128-138 (2013).
27. Cao, D. J. et al. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc. Natl Acad. Sci. USA 108, 4123-4128 (2011).
28. Oka, T. et al. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 485, 251-255 (2012).
29. Shimada, K. et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36, 401-414 (2012).
30. Ikeda, Y. et al. Endogenous Drp1 mediates mitochondrial autophagy and protects the heart against energy stress. Circ. Res. 116, 264-278 (2015).
31. Carreira, R. S., Lee, Y., Ghochani, M., Gustafsson, A. B. & Gottlieb, R. A. Cyclophilin D is required for mitochondrial removal by autophagy in cardiac cells. Autophagy 6, 462-472 (2010).
32. Eiyama, A. & Okamoto, K. PINK1/Parkin-mediated mitophagy in mammalian cells. Curr. Opin. Cell Biol. 33, 95-101 (2015).
33. Gottlieb, R. A. & Bernstein, D. Mitochondrial remodeling: rearranging, recycling, and reprogramming. Cell Calcium 60, 88-101 (2016).
34. Saito, T. & Sadoshima, J. The molecular mechanisms of mitochondrial autophagy/mitophagy in the heart. Circ. Res. 116, 1477-1490 (2015).
35. Heo, J.-M., Ordureau, A., Paulo, J. A., Rinehart, J. & Harper, J. W. The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN/ NDP52 recruitment and TBK1 activation to promote mitophagy. Mol. Cell 60, 7-20 (2015).
36. Lazarou, M. et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 524, 309-314 (2015).
37. Roberts, R. F., Tang, M. Y., Fon, E. A. & Durcan, T. M. Defending the mitochondria: the pathways of mitophagy and mitochondrial-derived vesicles. Int. J. Biochem. Cell Biol. 79, 427-436 (2016).
38. Cadete, V. et al. Mitochondrial-derived vesicle formation in cardiac mitochondrial quality control [abstract]. FASEB J. 29 (Suppl.), 1036.1 (2015).
39. Huang, C. et al. Preconditioning involves selective mitophagy mediated by Parkin and p62/SQSTM1. PLoS ONE 6, e20975 (2011).
40. Brennan, J. P. et al. Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of KATP channel activation. Cardiovasc. Res. 72, 313-321 (2006).
41. Minners, J. et al. Dinitrophenol, cyclosporin A, and trimetazidine modulate preconditioning in the isolated rat heart: support for a mitochondrial role in cardioprotection. Cardiovasc. Res. 47, 68-73 (2000).
42. Andres, A. M. et al. Mitophagy is required for acute cardioprotection by simvastatin. Antioxid. Redox Signal. 21, 1960-1973 (2014).
43. Stotland, A. & Gottlieb, R. A. α-MHC MitoTimer mouse: in vivo mitochondrial turnover model reveals remarkable mitochondrial heterogeneity in the heart. J. Mol. Cell. Cardiol. 90, 53-58 (2016).
44. McWilliams, T. G. & Prescott, A. R. mito-QC illuminates mitophagy and mitochondrial architecture in vivo. J. Cell Biol. 214, 333-345 (2016).
45. Sun, N. et al. Measuring in vivo mitophagy. Mol. Cell 60, 685-696 (2015).
46. Pompe, J. C. Over idiopathische hypertrophie van het hart [in Dutch]. Ned. Tijdschr. Geneeskd. 76, 304-312 (1932).
47. Hers, H. G. á-glucosidase deficiency in generalized glycogenstorage disease (Pompe's disease). Biochem. J. 86, 11-16 (1963).
48. Jiang, S. et al. Starch binding domain-containing protein 1/genethonin 1 is a novel participant in glycogen metabolism. J. Biol. Chem. 285, 34960-34971 (2010).
49. Jiang, S., Wells, C. D. & Roach, P. J. Starch-binding domain-containing protein 1 (Stbd1) and glycogen metabolism: identification of the Atg8 family interacting motif (AIM) in Stbd1 required for interaction with GABARAPL1. Biochem. Biophys. Res. Commun. 413, 420-425 (2011).
50. Mellor, K. M., Varma, U., Stapleton, D. & Delbridge, L. M. D. Cardiomyocyte glycophagy is regulated by insulin and exposure to high extracellular glucose. Am. J. Physiol. Heart Circ. Physiol. 306, H1240-H1245 (2014).
51. Kondomerkos, D. J., Kalamidas, S. A. & Kotoulas, O. B. An electron microscopic and biochemical study of the effects of glucagon on glycogen autophagy in the liver and heart of newborn rats. Microsc. Res. Tech. 63, 87-93 (2004).
52. Kondomerkos, D. J., Kalamidas, S. A., Kotoulas, O. B. & Hann, A. C. Glycogen autophagy in the liver and heart of newborn rats. The effects of glucagon, adrenalin or rapamycin. Histol. Histopathol. 20, 689-696 (2005).
53. Zirin, J., Nieuwenhuis, J. & Perrimon, N. Role of autophagy in glycogen breakdown and its relevance to chloroquine myopathy. PLoS Biol. 11, e1001708 (2013).
54. Singh, P. K. & Singh, S. Changing shapes of glycogen-autophagy nexus in neurons: perspective from a rare epilepsy. Front. Neurol. 6, 14 (2015).
55. Kalamidas, S. A. & Kondomerkos, D. J. The administration of nonmetabolizable glucose analogues fails to suppress the development of glycogen autophagy in newborn rat hepatocytes. Microsc. Res. Tech. 73, 1009-1014 (2010).
56. Kakhlon, O. et al. Polyglucosan neurotoxicity caused by glycogen branching enzyme deficiency can be reversed by inhibition of glycogen synthase. J. Neurochem. 127, 101-113 (2013).
57. Duran, J., Gruart, A., Garcia-Rocha, M., Delgado-Garcia, J. M. & Guinovart, J. J. Glycogen accumulation underlies neurodegeneration and autophagy impairment in Lafora disease. Hum. Mol. Genet. 23, 3147-3156 (2014).
58. Chandramouli, C. et al. Myocardial glycogen dynamics: new perspectives on disease mechanisms. Clin. Exp. Pharmacol. Physiol. 42, 415-425 (2015).
59. Troncoso, R. et al. Energy-preserving effects of IGF-1 antagonize starvation-induced cardiac autophagy. Cardiovasc. Res. 93, 320-329 (2012).
60. Riehle, C. et al. Insulin receptor substrate signaling suppresses neonatal autophagy in the heart. J. Clin. Invest. 123, 5319-5333 (2013).
61. Riehle, C. & Abel, E. D. Insulin regulation of myocardial autophagy. Circ. J. 78, 2569-2576 (2014).
62. Sciarretta, S. et al. Rheb is a critical regulator of autophagy during myocardial ischemia: pathophysiological implications in obesity and metabolic syndrome. Circulation 125, 1134-1146 (2012).
63. Maejima, Y. et al. Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2. Nat. Med. 19, 1478-1488 (2013).
64. Zalckvar, E. et al. DAP-kinase-mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl-XL and induction of autophagy. EMBO Rep. 10, 285-292 (2009).
65. Gurkar, A. U. et al. Identification of ROCK1 kinase as a critical regulator of Beclin1-mediated autophagy during metabolic stress. Nat. Commun. 4, 2189 (2013).
66. Wei, Y., Pattingre, S., Sinha, S., Bassik, M. & Levine, B. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol. Cell 30, 678-688 (2008).
67. Yin, X. et al. miR-30a downregulation aggravates pressure overload-induced cardiomyocyte hypertrophy. Mol. Cell. Biochem. 379, 1-6 (2013).
68. Lai, L., Wang, N., Zhu, G., Duan, X. & Ling, F. MiRNA-30e mediated cardioprotection of ACE2 in rats with doxorubicin-induced heart failure through inhibiting cardiomyocytes autophagy. Life Sci. 169, 69-75 (2017).
69. Ucar, A. et al. The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat. Commun. 3, 1078 (2012).
70. Li, Q. et al. Overexpression of microRNA-99a attenuates heart remodelling and improves cardiac performance after myocardial infarction. J. Cell. Mol. Med. 18, 919-928 (2014).
71. Zou, Y., Liu, W., Zhang, J. & Xiang, D. miR-153 regulates apoptosis and autophagy of cardiomyocytes by targeting Mcl-1. Mol. Med. Rep. 14, 1033-1039 (2016).
72. Higashi, K. et al. MicroRNA-145 repairs infarcted myocardium by accelerating cardiomyocyte autophagy. Am. J. Physiol. Heart Circ. Physiol. 309, H1813-H1826 (2015).
73. Cheng, M. et al. MicroRNA-181a suppresses parkin-mediated mitophagy and sensitizes neuroblastoma cells to mitochondrial uncoupler-induced apoptosis. Oncotarget 7, 42274-42287 (2016).
74. Mo, J., Zhang, D. & Yang, R. MicroRNA-195 regulates proliferation, migration, angiogenesis and autophagy of endothelial progenitor cells by targeting GABARAPL1. Biosci. Rep. 36, e00396 (2016).
75. Barile, L., Moccetti, T., Marban, E. & Vassalli, G. Roles of exosomes in cardioprotection. Eur. Heart J. http://dx.doi.org/10.1093/eurheartj/ehw304 (2016).
76. Ibrahim, A. G., Cheng, K. & Marban, E. Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Rep. 2, 606-619 (2014).
77. Giricz, Z. et al. Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles. J. Mol. Cell. Cardiol. 68, 75-78 (2014).
78. Liu, Y. et al. Autosis is a Na+,K+-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia. Proc. Natl Acad. Sci. USA 110, 20364-20371 (2013).
79. Wang, L. et al. Decreased autophagy: a major factor for cardiomyocyte death induced by beta1-adrenoceptor autoantibodies. Cell Death Dis. 6, e1862 (2015).
80. Gupta, M. K. et al. UBC9-mediated sumoylation favorably impacts cardiac function in compromised hearts. Circ. Res. 118, 1894-1905 (2016).
81. Shirakabe, A. et al. Drp1-dependent mitochondrial autophagy plays a protective role against pressure overload-induced mitochondrial dysfunction and heart failure. Circulation 133, 1249-1263 (2016).
82. Saito, T. et al. Autophagic vacuoles in cardiomyocytes of dilated cardiomyopathy with initially decompensated heart failure predict improved prognosis. Autophagy 12, 579-587 (2016).
83. Schlossarek, S., Mearini, G. & Carrier, L. Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: mechanisms and therapeutic opportunities. J. Mol. Cell. Cardiol. 50, 613-620 (2011).
84. Linton, P. J., Gurney, M., Sengstock, D., Mentzer, R. M. Jr & Gottlieb, R. A. This old heart: cardiac aging and autophagy. J. Mol. Cell. Cardiol. 83, 44-54 (2015).
85. Ceylan-Isik, A. F. et al. Cardiomyocyte-specific deletion of endothelin receptor A rescues aging-associated cardiac hypertrophy and contractile dysfunction: role of autophagy. Basic Res. Cardiol. 108, 335 (2013).
86. Mellor, K. M., Reichelt, M. E. & Delbridge, L. M. Autophagy anomalies in the diabetic myocardium. Autophagy 7, 1263-1267 (2011).
87. Zhang, Y. & Ren, J. Epigenetics and obesity cardiomyopathy: from pathophysiology to prevention and management. Pharmacol. Ther. 161, 52-66 (2016).
88. Ceylan-Isik, A. F. et al. Cardiac overexpression of metallothionein rescues cardiac contractile dysfunction and endoplasmic reticulum stress but not autophagy in sepsis. J. Mol. Cell. Cardiol. 48, 367-378 (2010).
89. Yuan, H. et al. LPS-induced autophagy is mediated by oxidative signaling in cardiomyocytes and is associated with cytoprotection. Am. J. Physiol. Heart Circ. Physiol. 296, H470-H479 (2009).
90. Gustafsson, A. B. & Gottlieb, R. A. Autophagy in ischemic heart disease. Circ. Res. 104, 150-158 (2009).
91. Matsui, Y. et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ. Res. 100, 914-922 (2007).
92. Li, D. L. et al. Doxorubicin blocks cardiomyocyte autophagic flux by inhibiting lysosome acidification. Circulation 133, 1668-1687 (2016).
93. Kostin, S. et al. Myocytes die by multiple mechanisms in failing human hearts. Circ. Res. 92, 715-724 (2003).
94. Tannous, P. et al. Autophagy is an adaptive response in desmin-related cardiomyopathy. Proc. Natl Acad. Sci. USA 105, 9745-9750 (2008).
95. Porrello, E. R. et al. Angiotensin II type 2 receptor antagonizes angiotensin II type 1 receptor-mediated cardiomyocyte autophagy. Hypertension 53, 1032-1040 (2009).
96. Porrello, E. R. & Delbridge, L. M. Cardiomyocyte autophagy is regulated by angiotensin II type 1 and type 2 receptors. Autophagy 5, 1215-1216 (2009).
97. Li, B., Chi, R. F., Qin, F. Z. & Guo, X. F. Distinct changes of myocyte autophagy during myocardial hypertrophy and heart failure: association with oxidative stress. Exp. Physiol. 101, 1050-1063 (2016).
98. Pfeifer, U., Fohr, J., Wilhelm, W. & Dammrich, J. Short-term inhibition of cardiac cellular autophagy by isoproterenol. J. Mol. Cell. Cardiol. 19, 1179-1184 (1987).
99. Zhu, H. et al. Cardiac autophagy is a maladaptive response to hemodynamic stress. J. Clin. Invest. 117, 1782-1793 (2007).
100. Ha, T. et al. Attenuation of cardiac hypertrophy by inhibiting both mTOR and NFkappaB activation in vivo. Free Radic. Biol. Med. 39, 1570-1580 (2005).
101. Kuzman, J. A., O'Connell, T. D. & Gerdes, A. M. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy. Endocrinology 148, 3477-3484 (2007).
102. Shirakabe, A., Ikeda, Y., Sciarretta, S., Zablocki, D. K. & Sadoshima, J. Aging and autophagy in the heart. Circ. Res. 118, 1563-1576 (2016).
103. Wohlgemuth, S. E. et al. Autophagy in the heart and liver during normal aging and calorie restriction. Rejuvenation Res. 10, 281-292 (2007).
104. Taneike, M. et al. Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy 6, 600-606 (2010).
105. Song, Z. et al. Essential role for UVRAG in autophagy and maintenance of cardiac function. Cardiovasc. Res. 101, 48-56 (2014).
106. Hua, Y. et al. Chronic Akt activation accentuates aging-induced cardiac hypertrophy and myocardial contractile dysfunction: role of autophagy. Basic Res. Cardiol. 106, 1173-1191 (2011).
107. Ma, L. et al. Restoring pharmacologic preconditioning in the aging heart: role of mitophagy/autophagy. J. Gerontol. A Biol. Sci. Med. Sci. http://dx.doi.org/ 10.1093/gerona/glw168 (2016).
108. Boyle, A. J. et al. Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy. Exp. Gerontol. 46, 549-559 (2011).
109. Inuzuka, Y. et al. Suppression of phosphoinositide 3-kinase prevents cardiac aging in mice. Circulation 120, 1695-1703 (2009).
110. Khalil, H. et al. Aging is associated with hypermethylation of autophagy genes in macrophages. Epigenetics 11, 381-388 (2016).
111. Russell, R. R. III et al. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J. Clin. Invest. 114, 495-503 (2004).
112. Huang, L. et al. The AMPK agonist PT1 and mTOR inhibitor 3HOI-BA-01 protect cardiomyocytes after ischemia through induction of autophagy. J. Cardiovasc. Pharmacol. Ther. 21, 70-81 (2016).
113. Huang, C. et al. Autophagy induced by ischemic preconditioning is essential for cardioprotection. J. Cardiovasc. Transl. Res. 3, 365-373 (2010).
114. Wei, C., Li, H., Han, L., Zhang, L. & Yang, X. Activation of autophagy in ischemic postconditioning contributes to cardioprotective effects against ischemia/ reperfusion injury in rat hearts. J. Cardiovasc. Pharmacol. 61, 416-422 (2013).
115. Yitzhaki, S. et al. Autophagy is required for preconditioning by the adenosine A1 receptor-selective agonist CCPA. Basic Res. Cardiol. 104, 157-167 (2009).
116. Yao, H., Han, X. & Han, X. The cardioprotection of the insulin-mediated PI3K/Akt/mTOR signaling pathway. Am. J. Cardiovasc. Drugs 14, 433-442 (2014).
117. Lal, H., Ahmad, F., Woodgett, J. & Force, T. The GSK-3 family as therapeutic target for myocardial diseases. Circ. Res. 116, 138-149 (2015).
118. Zhai, P. & Sadoshima, J. Glycogen synthase kinase-3β controls autophagy during myocardial ischemia and reperfusion. Autophagy 8, 138-139 (2012).
119. Hariharan, N., Zhai, P. & Sadoshima, J. Oxidative stress stimulates autophagic flux during ischemia/ reperfusion. Antioxid. Redox Signal. 14, 2179-2190 (2011).
120. Hamacher-Brady, A., Brady, N. R. & Gottlieb, R. A. Enhancing macroautophagy protects against ischemia/ reperfusion injury in cardiac myocytes. J. Biol. Chem. 281, 29776-29787 (2006).
121. Ma, X. et al. Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia/ reperfusion injury. Circulation 125, 3170-3181 (2012).
122. Li, S. et al. Autophagy protects cardiomyocytes from the myocardial ischaemia-reperfusion injury through the clearance of CLP36. Open Biol. 6, 160177 (2016).
123. Kappel, B. A. et al. Post-translational modulation of FoxO1 contributes to cardiac remodeling in post-ischemic heart failure. Atherosclerosis 249, 148-156 (2016).
124. Ma, X. et al. Regulation of the transcription factor EB-PGC1α axis by beclin-1 controls mitochondrial quality and cardiomyocyte death under stress. Mol. Cell. Biol. 35, 956-976 (2015).
125. Mellor, K. M., Bell, J. R., Young, M. J., Ritchie, R. H. & Delbridge, L. M. Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice. J. Mol. Cell. Cardiol. 50, 1035-1043 (2011).
126. Xie, Z. et al. Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice. Diabetes 60, 1770-1778 (2011).
127. Munasinghe, P. E. et al. Type-2 diabetes increases autophagy in the human heart through promotion of Beclin-1 mediated pathway. Int. J. Cardiol. 202, 13-20 (2016).
128. Wang, B. et al. Resveratrol-enhanced autophagic flux ameliorates myocardial oxidative stress injury in diabetic mice. J. Cell. Mol. Med. 18, 1599-1611 (2014).
129. Trivedi, P. C. et al. Glucolipotoxicity diminishes cardiomyocyte TFEB and inhibits lysosomal autophagy during obesity and diabetes. Biochim. Biophys. Acta 1861, 1893-1910 (2016).
130. Xu, X. et al. Diminished autophagy limits cardiac injury in mouse models of type 1 diabetes. J. Biol. Chem. 288, 18077-18092 (2013).
131. Andres, A. M. et al. Discordant signaling and autophagy response to fasting in hearts of obese mice: implications for ischemia tolerance. Am. J. Physiol. Heart Circ. Physiol. 311, H219-H228 (2016).
132. Xu, X., Hua, Y., Nair, S., Zhang, Y. & Ren, J. Akt2 knockout preserves cardiac function in high-fat diet-induced obesity by rescuing cardiac autophagosome maturation. J. Mol. Cell. Biol. 5, 61-63 (2013).
133. Jaishy, B. et al. Lipid-induced NOX2 activation inhibits autophagic flux by impairing lysosomal enzyme activity. J. Lipid Res. 56, 546-561 (2015).
134. Montaigne, D. et al. Myocardial contractile dysfunction is associated with impaired mitochondrial function and dynamics in type 2 diabetic but not in obese patients. Circulation 130, 554-564 (2014).
135. Zhang, J. et al. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice. Clin. Sci. (Lond.) 130, 625-641 (2016).
136. He, C., Zhu, H., Li, H., Zou, M. H. & Xie, Z. Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes. Diabetes 62, 1270-1281 (2013).
137. Pei, X. M. et al. Protective effects of desacyl ghrelin on diabetic cardiomyopathy. Acta Diabetol. 52, 293-306 (2015).
138. Kanamori, H. et al. Autophagic adaptations in diabetic cardiomyopathy differ between type 1 and type 2 diabetes. Autophagy 11, 1146-1160 (2015).
139. Liu, J. et al. (-)-epigallocatechin-3-gallate attenuated myocardial mitochondrial dysfunction and autophagy in diabetic Goto-Kakizaki rats. Free Radic. Res. 48, 898-906 (2014).
140. Yuan, X. et al. Chloroquine improves left ventricle diastolic function in streptozotocin-induced diabetic mice. Drug Des. Devel. Ther. 10, 2729-2737 (2016).
141. Levine, B., Packer, M. & Codogno, P. Development of autophagy inducers in clinical medicine. J. Clin. Invest. 125, 14-24 (2015).
142. Bhuiyan, M. S. et al. Enhanced autophagy ameliorates cardiac proteinopathy. J. Clin. Invest. 123, 5284-5297 (2013).
143. Chen, H. H. et al. Fluorescence tomography of rapamycin-induced autophagy and cardioprotection in vivo. Circ. Cardiovasc. Imaging 6, 441-447 (2013).
144. Gurusamy, N. et al. Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway. Cardiovasc. Res. 86, 103-112 (2010).
145. Wang, L. Q., Cheng, X. S., Huang, C. H., Huang, B. & Liang, Q. Rapamycin protects cardiomyocytes against anoxia/reoxygenation injury by inducing autophagy through the PI3k/Akt pathway. J. Huazhong Univ. Sci. Technolog. Med. Sci. 35, 10-15 (2015).
146. Yamamoto, T. et al. Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion. PLoS ONE 9, e98972 (2014).
147. Xie, H. et al. Hydrogen sulfide protects against myocardial ischemia and reperfusion injury by activating AMP-activated protein kinase to restore autophagic flux. Biochem. Biophys. Res. Commun. 458, 632-638 (2015).
148. Xie, M. et al. Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy. Circulation 129, 1139-1151 (2014).
149. Morales, C. R. et al. Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression. Sci. Signal. 9, ra34 (2016).
150. Rothermel, B. A. & Hill, J. A. Autophagy in load-induced heart disease. Circ. Res. 103, 1363-1369 (2008).
151. Yasuda, H. et al. Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury. Am. J. Physiol. Renal Physiol. 294, F1050-F1058 (2008).
152. Ridout, R. M., Wildenthal, K. & Decker, R. S. Influence of agents that alter lysosomal function on fetal mouse hearts recovering from anoxia and substrate depletion. J. Mol. Cell. Cardiol. 18, 867-876 (1986).
153. Gupta, S. K. et al. Preclinical development of a microRNA-based therapy for elderly patients with myocardial infarction. J. Am. Coll. Cardiol. 68, 1557-1571 (2016).
154. Salabei, J. K. et al. Verapamil stereoisomers induce antiproliferative effects in vascular smooth muscle cells via autophagy. Toxicol. Appl. Pharmacol. 262, 265-272 (2012).
155. Chiao, Y. A. et al. Rapamycin transiently induces mitochondrial remodeling to reprogram energy metabolism in old hearts. Aging (Albany NY) 8, 314-327 (2016).
156. Aranguiz-Urroz, P. et al. Beta2-adrenergic receptor regulates cardiac fibroblast autophagy and collagen degradation. Biochim. Biophys. Acta 1812, 23-31 (2011).
157. Bahro, M., Dammrich, J. & Pfeifer, U. Short-term inhibition of cellular autophagy by isoproterenol in the submandibular gland. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 53, 32-36 (1987).
158. Shimomura, M. et al. Acute effects of statin on reduction of angiopoietin-like 2 and glyceraldehyde-derived advanced glycation end-products levels in patients with acute myocardial infarction: a message from SAMIT (Statin for Acute Myocardial Infarction Trial). Heart Vessels 31, 1583-1589 (2016).
159. Post, S. et al. Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial. Catheter Cardiovasc. Interv. 80, 756-765 (2012).
160. Delbridge, A. R., Grabow, S., Strasser, A. & Vaux, D. L. Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies. Nat. Rev. Cancer 16, 99-109 (2016).
161. Lee, Y., Hong, Y., Lee, S. R., Chang, K. T. & Hong, Y. Autophagy contributes to retardation of cardiac growth in diabetic rats. Lab. Anim. Res. 28, 99-107 (2012).
162. Eguchi, M. et al. Ischemia-reperfusion injury leads to distinct temporal cardiac remodeling in normal versus diabetic mice. PLoS ONE 7, e30450 (2012).
163. Sun, S. et al. Lin28a protects against diabetic cardiomyopathy via the PKA/ROCK2 pathway. Biochem. Biophys. Res. Commun. 469, 29-36 (2016).
164. Zhao, Y. et al. Heme oxygenase-1 prevents cardiac dysfunction in streptozotocin-diabetic mice by reducing inflammation, oxidative stress, apoptosis and enhancing autophagy. PLoS ONE 8, e75927 (2013).
165. Zhang, M. et al. MST1 coordinately regulates autophagy and apoptosis in diabetic cardiomyopathy in mice. Diabetologia 59, 2435-2447 (2016).
166. Lee, J. H. et al. Diet control to achieve euglycemia induces significant loss of heart and liver weight via increased autophagy compared with ad libitum diet in diabetic rats. Exp. Mol. Med. 46, e111 (2014).
167. Marsh, S. A., Powell, P. C., Dell'italia, L. J. & Chatham, J. C. Cardiac O-GlcNAcylation blunts autophagic signaling in the diabetic heart. Life Sci. 92, 648-656 (2013).
168. Gao, H., Yang, Q., Dong, R., Hou, F. & Wu, Y. Sequential changes in autophagy in diabetic cardiac fibrosis. Mol. Med. Rep. 13, 327-332 (2016).
169. Lai, C. H. et al. Multi-strain probiotics inhibit cardiac myopathies and autophagy to prevent heart injury in high-fat diet-fed rats. Int. J. Med. Sci. 13, 277-285 (2016).
170. Chou, I. P. et al. Adiponectin receptor 1 overexpression reduces lipid accumulation and hypertrophy in the heart of diet-induced obese mice - possible involvement of oxidative stress and autophagy. Endocr. Res. 39, 173-179 (2014).
171. Russo, S. B. et al. Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes. J. Clin. Invest. 122, 3919-3930 (2012).
172. Guo, R., Zhang, Y., Turdi, S. & Ren, J. Adiponectin knockout accentuates high fat diet-induced obesity and cardiac dysfunction: role of autophagy. Biochim. Biophys. Acta 1832, 1136-1148 (2013).
173. Cui, M., Yu, H., Wang, J., Gao, J. & Li, J. Chronic caloric restriction and exercise improve metabolic conditions of dietary-induced obese mice in autophagy correlated manner without involving AMPK. J. Diabetes Res. 2013, 852754 (2013).
174. He, C. et al. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature 481, 511-515 (2012).
175. Xu, X. & Ren, J. Macrophage migration inhibitory factor (MIF) knockout preserves cardiac homeostasis through alleviating Akt-mediated myocardial autophagy suppression in high-fat diet-induced obesity. Int. J. Obes. (Lond.) 39, 387-396 (2015).
176. Hsu, H. C. et al. Time-dependent cellular response in the liver and heart in a dietary-induced obese mouse model: the potential role of ER stress and autophagy. Eur. J. Nutr. 55, 2031-2043 (2016).
177. Lancel, S. et al. Carbon monoxide improves cardiac function and mitochondrial population quality in a mouse model of metabolic syndrome. PLoS ONE 7, e41836 (2012).